Branded Formulations present an opportunity to provide patients in India with world class treatment options that are effective and affordable. Our Branded Formulations business has positioned us as a leading biologics-led, specialty products company focused on chronic therapy areas. We have built considerable brand equity with doctors and patients over the years through our affordable and differentiated portfolio in challenging disease spaces. A combination of products, patients and physician support programs have enabled us to achieve market leadership in the therapeutic areas of diabetology, oncology, immunology and critical care.
CONTACT
Group Companies
BIOCON BIOLOGICS
Branded Formulations
A strong value builder
A combination of products, patients and physician support programs have enabled us to achieve market leadership in the therapeutic areas of diabetology, oncology, immunology and critical care.
The growth of our flagship brands, especially in Metabolics and Oncotherapeutics, have indicated their treatment efficacies. Brands like Insugen®, Basalog®, BIOMAb EGFR®, CANMAb™, and ALZUMAb® are among the leading brands in their respective segments.
Our expanding portfolio includes several new, first-of-its-kind offerings in the Indian market. These were introduced to patients and physicians across India through awareness programs, which are regularly conducted to enhance their knowledge on disease prevention, detection and management.
Addressing the COVID-19 Pandemic
The Biocon Group addressed the COVID-19 pandemic unitedly with undeterred spirit and unwavering purpose.
Know more
about us
CORPORATE GOVERNANCE
KEY THERAPEUTIC AREAS
RESEARCH SERVICES
OUR CULTURE
